Trending Stocks, Investing Tips, and Market Insights on Stockchase

Jim Cramer - Mad Money
Jim Cramer - Mad Money on Mad Money on CNBC04/08/2026 at 01:28am

US EQUITIES

unlockUnlock Rating

Was up 23.9% last month. Medtech has slumped for a while, but is rallying now as investors look for tech growth outside AI stocks. They reported a good quarter last week. Wished the PE were lower.

premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

The Monthly Gems by Allan Tong
The Monthly Gems by Allan Tong on Stockchase03/08/2026 at 11:31pm

NORTH AMERICAN

unlockUnlock Rating

This pharma company is a major holding within XLV, but worth owning itself. The company just reported Q2 earnings, with total net revenues beating, bolstered by 10.2% sales growth. To replace its blockbuster drug, Humira, AbbVie launched Skyrizi which boasts global sales of $5.5 billion, and Rinvoq (global sales of over $2.5 billion). AbbVie's overall sales growth was 10.2%.

Most Anticipated Earnings: OLA-T, SU-T and more Canadian Companies Reporting Earnings this Week (Aug 03-07)
03/08/2026 at 12:08pm

Most Anticipated Earnings: OLA-T, SU-T and more Canadian Companies Reporting Earnings this Week (Aug 03-07)

Here are the Canadian companies listed on Stockchase who are reporting earnings this week: 🛢Basic Materials ⚡ Energy 🏛 Financials 💻 Technology 👨‍⚕️ Healthcare 🚚 Industrials 🛍 Consumer 💡 Utilities Use this list wisely to identify buying opportunities.Happy trading !!! read more